Clinical and epidemiological issues in mammographic density

被引:96
作者
Assi, Valentina [1 ]
Warwick, Jane [1 ]
Cuzick, Jack [1 ]
Duffy, Stephen W. [1 ]
机构
[1] Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England
关键词
BREAST-CANCER RISK; HORMONE REPLACEMENT THERAPY; ESTROGEN-RECEPTOR STATUS; PARENCHYMAL PATTERNS; TISSUE COMPOSITION; PREDICTION MODEL; FAMILY-HISTORY; GAIL MODEL; FOLLOW-UP; WOMEN;
D O I
10.1038/nrclinonc.2011.173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mammographic density is associated with an increased risk of breast cancer, and of all known breast cancer risk factors has the greatest attributable fraction. Mammographic density is estimated to account for 16% of all breast cancers, but can be altered by endogenous and exogenous hormonal factors, and generally declines with age. Confounding factors such as age, parity, menopausal status and BMI make the interpretation of mammographic density particularly challenging. Furthermore, none of the established means of measuring mammographic density are entirely satisfactory because they are time consuming or subjective. It is hoped that by adding information regarding mammographic density to existing models of breast cancer risk assessment, the accuracy of individual risk assessments can be improved. Although mammographic density has clearly been shown to be a powerful factor for predicting the risk of developing breast cancer, its potential role in assessing hormonal preventive regimens and helping to tailor screening algorithms cannot be fully realized until we have more-precise, simple and reproducible density measures.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 114 条
[1]   Screen-Film Mammographic Density and Breast Cancer Risk: A Comparison of the Volumetric Standard Mammogram Form and the Interactive Threshold Measurement Methods [J].
Aitken, Zoe ;
McCormack, Valerie A. ;
Highnam, Ralph P. ;
Martin, Lisa ;
Gunasekara, Anoma ;
Melnichouk, Olga ;
Mawdsley, Gord ;
Peressotti, Chris ;
Yaffe, Martin ;
Boyd, Norman F. ;
Silva, Isabel dos Santos .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) :418-428
[2]   Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme [J].
Amir, E ;
Evans, DG ;
Shenton, A ;
Lalloo, F ;
Moran, A ;
Boggis, C ;
Wilson, M ;
Howell, A .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (11) :807-814
[3]  
[Anonymous], U HOSP S MANCH
[4]  
[Anonymous], 2011, NHS BREAST SCREEN PR
[5]  
[Anonymous], 2011, KARMA
[6]  
[Anonymous], 2012, AR YOU DENS EXP BEST
[7]   Prospective breast cancer risk prediction model for women undergoing screening mammography [J].
Barlow, William E. ;
White, Emily ;
Ballard-Barbash, Rachel ;
Vacek, Pamela M. ;
Titus-Ernstoff, Linda ;
Carney, Patricia A. ;
Tice, Jeffrey A. ;
Buist, Diana S. M. ;
Geller, Berta M. ;
Rosenberg, Robert ;
Yankaskas, Bonnie C. ;
Kerlikowske, Karla .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1204-1214
[8]   Is mammography adequate for screening women with inherited BRCA mutations and low breast density? [J].
Bigenwald, Rachel Z. ;
Warner, Ellen ;
Gunasekara, Anoma ;
Hill, Kimberley A. ;
Causer, Petrina A. ;
Messner, Sandra J. ;
Eisen, Andrea ;
Plewes, Donald B. ;
Narod, Steven A. ;
Zhang, Liying ;
Yaffe, Martin J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (03) :706-711
[9]   Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) Model for Breast Cancer Risk Prediction in Women With Atypical Hyperplasia [J].
Boughey, Judy C. ;
Hartmann, Lynn C. ;
Anderson, Stephanie S. ;
Degnim, Amy C. ;
Vierkant, Robert A. ;
Reynolds, Carol A. ;
Frost, Marlene H. ;
Pankratz, V. Shane .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) :3591-3596
[10]  
Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048